Greenland Capital Management’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

Greenland Capital Management’s Portfolio NUVB.WS Stock Details NUVB.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-348,960	Closed	-$115K	–	373
2025 Q4	$115K	Buy	348,960 +4,300	+1%	+$944	0.01%	306
2025 Q3	$69.7K	Hold	344,660	–	–	0.01%	296
2025 Q2	$93K	Hold	344,660	–	–	0.01%	314
2025 Q1	$54.5K	Hold	344,660	–	–	0.01%	285
2024 Q4	$79.3K	Hold	344,660	–	–	0.01%	312
2024 Q3	$33.7K	Hold	344,660	–	–	﹤0.01%	318
2024 Q2	$55.1K	Hold	344,660	–	–	0.01%	293
2024 Q1	$104K	Buy	+344,660	New	+$41K	0.01%	327

Greenland Capital Management's NUVB.WS Position: Q1 2026 in Review

Greenland Capital Management sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q1 2026, closing a stake of 348,960 shares — an estimated $115K sold.

Greenland Capital Management first reported a position in NUVB.WS in Q1 2024 and held it in 8 quarters. The position peaked at $115K in Q4 2025. 0 funds tracked by Wall St. Rank hold NUVB.WS as of Q1 2026.

Greenland Capital Management reported no remaining Nuvation Bio Inc Warrants position as of Q1 2026 after selling out during the quarter.
Greenland Capital Management sold 348,960 Nuvation Bio Inc Warrants shares in Q1 2026, an estimated $115K.
Greenland Capital Management first reported a position in Nuvation Bio Inc Warrants in Q1 2024 and held it in 8 quarters.
Greenland Capital Management's Nuvation Bio Inc Warrants position peaked at $115K in Q4 2025.
0 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q1 2026.

Based on Greenland Capital Management's 13F filing for Q1 2026, filed 15 May 2026.